Citations

Showing 10 of 108081 citations.

Toward the Development of a Glucose Dehydrogenase-Based Saliva Glucose Sensor Without the Need for Sample Preparation
Lin, Chi, Pratt, Breanna, Honikel, Mackenzie M. , Jenish, Alaina, Ramesh, Bhavna, Alkhan, Amnah, Belle, Jeffrey T. La , La Belle, Jeffrey T, Ramesh, Bhavna

Mayo Clinic

Journal of Diabetes Science and Technology | June 19, 2017 | Volume: 12 | Issue: 1 | Pages: 83-89

10.1177/1932296817712526 | PMID 28627257 Get It

Background: Strict glycemic control is known to be a vital key in the management of diabetes mellitus (DM). However, traditional methods face limitations in their efficacy due to the pain and invasiveness of needle pricking which often discourages DM patients from performing the required number of tests per day. Saliva glucose (SG) sensing has long been considered a noninvasive alternative to blood glucose monitoring for diabetes management, however the sample preparation and sensor detection limit have been deemed as challenges to overcome. Herein, we describe a preliminary clinical validation of a disposable SG sensor without any requirement for sample preparation. Methods: The sensor utilizes glucose dehydrogenase flavine-adenine dinucleotide (GDH-FAD) in conjunction with disposable screen printed electrodes to measure glucose levels in saliva collected directly from 9 healthy subjects. Cyclic voltammetry and amperometric-time (Amp-it) assays were used to develop calibration curves and test subjects. Sensor calibration was performed using simulated saliva at 6.5 pH and 37ºC. Results: The lower limit of detection was determined to be 0.11 mg/dL. A lag time of 15 minutes with a positive correlation between SG and BG levels was found, which agrees with literature results. The detected SG ranges from 2.38 to 3.40 mg/dL over a BG range of 90 to 143 mg/dL. Conclusion: This is the first reported use of measuring SG with GDH-FAD without prior sample preparation. Upon optimization, the sensor has the potential to serve as a supplement to blood glucose monitoring.
Migraine Subclassification via a Data‐Driven Automated Approach Using Multimodality Factor Mixture Modeling of Brain Structure Measurements
Si, Bing , Li, Jing , Schwedt, Todd J. , Wu, Teresa , Chong, Catherine D. , Si, Bing

Mayo Clinic

Headache: The Journal of Head and Face Pain | June 19, 2017 | Volume: 57 | Issue: 7 | Pages: 1051-1064

10.1111/head.13121 | PMID 28627714 Get It

Background The current subclassification of migraine is according to headache frequency and aura status. The variability in migraine symptoms, disease course, and response to treatment suggest the presence of additional heterogeneity or subclasses within migraine. Objective The study objective was to subclassify migraine via a data‐driven approach, identifying latent factors by jointly exploiting multiple sets of brain structural features obtained via magnetic resonance imaging (MRI). Methods Migraineurs ( n = 66) and healthy controls ( n = 54) had brain MRI measurements of cortical thickness, cortical surface area, and volumes for 68 regions. A multimodality factor mixture model was used to subclassify MRIs and to determine the brain structural factors that most contributed to the subclassification. Clinical characteristics of subjects in each subgroup were compared. Results Automated MRI classification divided the subjects into two subgroups. Migraineurs in subgroup #1 had more severe allodynia symptoms during migraines (6.1 ± 5.3 vs. 3.6 ± 3.2, P = .03), more years with migraine (19.2 ± 11.3 years vs 13 ± 8.3 years, P = .01), and higher Migraine Disability Assessment (MIDAS) scores (25 ± 22.9 vs 15.7 ± 12.2, P = .04). There were not differences in headache frequency or migraine aura status between the two subgroups. Conclusions Data‐driven subclassification of brain MRIs based upon structural measurements identified two subgroups. Amongst migraineurs, the subgroups differed in allodynia symptom severity, years with migraine, and migraine‐related disability. Since allodynia is associated with this imaging‐based subclassification of migraine and prior publications suggest that allodynia impacts migraine treatment response and disease prognosis, future migraine diagnostic criteria could consider allodynia when defining migraine subgroups.
Chest X-ray of a patient with history of pleural effusion
Konik, Ewa, Schirger, John A., Schirger, John

Mayo Clinic

BMJ Case Reports | June 19, 2017 | Volume: 2017 | Issue: No issue available | Pages: bcr-2017-220769

10.1136/bcr-2017-220769 | PMID 28630248 Get It

The presented chest X-ray depicts the thoracic duct anatomy of a 50-year-old man who underwent heart transplantation. His postoperative course was complicated by Candida mediastinitis, treated with débridements and closure of the anterior chest wound with myocutaneous flaps. Postoperatively, he had persistent output from a right-sided chest tube. The fluid appeared milky and its triglycerides level was elevated at 254 mg/dL. The drainage persisted despite a low fat diet. The interventional radiologist identified a leak in the upper thoracic duct. It was embolised with coil and onyx. After the procedure, the chylous pleural effusions resolved. The thoracic duct has been visualised on subsequent chest X-rays (figures 1 and 2).
Recurrence Risk Stratification After Preoperative Chemoradiation of Esophageal Adenocarcinoma
Xi, Mian , Hallemeier, Christopher L. , Merrell, Kenneth W. , Murphy, Mariela A. Blum, Ho, Linus, Hofstetter, Wayne L. , Mehran, Reza J. , Lee, Jeffrey H. , Weston, Brian , Komaki, Ritsuko , Ajani, Jaffer A. , Hallemeier, Christopher Leigh , Liao, Zhongxing , Murphy, Mariela Blum, Bhutani, Manoop S. , Maru, Dipen Maheshbhai , Lin, Steven H. , Ajani, Jaffer A

Mayo Clinic

Annals of Surgery | June 17, 2017 | Volume: 268 | Issue: 2 | Pages: 289-295

10.1097/sla.0000000000002352 | PMID 28628563 Get It

Objective: To discern recurrence risk stratification and investigate its influence on postoperative surveillance in patients with esophageal adenocarcinoma (EAC) after neoadjuvant chemoradiotherapy (CRT). Background: Reports documenting recurrence risk stratification in EAC after neoadjuvant CRT are scarce. Methods: Between 1998 and 2014, 601 patients with EAC who underwent neoadjuvant CRT followed by esophagectomy were included for analysis. The pattern, site, timing, and frequency of the first recurrence and potential prognostic factors for developing recurrences were analyzed. This cohort was used as the training set to propose a recurrence risk stratification system, and the stratification was further validated in another cohort of 172 patients. Results: A total of 150 patients (25.0%) achieved pathologic complete response (pCR) after neoadjuvant CRT and the rest were defined as the non-pCR group (n = 451) in the training cohort. After a median follow-up of 63.6 months, the pCR group demonstrated a significantly lower locoregional (4.7% vs 19.1%) and distant recurrence rate (22.0% vs.44.6%) than the non-pCR group (P < 0.001). Based on independent prognostic factors, patients were stratified into 4 recurrence risk categories: pCR with clinical stage I/II, pCR with clinical stage III, non-pCR with pN0, and non-pCR with pN+, with corresponding 5-year recurrence-free survival rates of 88.7%, 65.8%, 55.3%, and 33.0%, respectively (P < 0.001). The risk stratification was reproducible in the validation cohort. Conclusions: We proposed a recurrence risk stratification system for EAC patients based on pathologic response and pretreatment clinical stage. Risk-based postoperative surveillance strategies could be developed for different risk categories.
Risk of Post-transplant Hepatocellular Carcinoma Recurrence Is Higher in Recipients of Livers From Male Than Female Living Donors
Han, Sangbin , Yang, Ju Dong , Choi, Gyu Sung, Jung, Gangha, Ahn, Joonghyun , Kim, Seonwoo , Ko, Justin Sangwook , Gwak, Mi Sook , Kwon, Choon Hyuck David , Leise, Michael D. , Kim, Gaab Soo , Yang, Ju Dong , Sinn, Dong Hyun , Kim, Jong Man , Gwak, Geum‐Youn , Heimbach, Julie K.

Mayo Clinic

Annals of Surgery | June 17, 2017 | Volume: 268 | Issue: 6 | Pages: 1043-1050

10.1097/sla.0000000000002318 | PMID 28628564 Get It

Objective: To evaluate the relationship between donor sex and hepatocellular carcinoma (HCC) recurrence after living donor liver transplantation. Background: HCC shows a male predominance in incidence and recurrence after tumor resection due to sex differences in hepatic sex hormone receptors. There have been no studies evaluating the importance of donor sex on post-transplant HCC recurrence. Methods: Of 384 recipients of livers, from living donors, for HCC: 104/120 who received grafts from female donors were matched with 246/264 who received grafts from male donors using propensity score matching, with an unfixed matching ratio based on factors like tumor biology. Survival analysis was performed with death as a competing risk event. The primary outcome was overall HCC recurrence. Results: The median follow-up time was 39 months. Before matching, recurrence probability at 1/2/5 years after transplantation was 6.1/9.7/12.7% in recipients with female donors and 11.7/19.2/25.3% in recipients with male donors. Recurrence risk was significantly higher with male donors in univariable analysis (hazard ratio [HR] = 2.04 [1.15–3.60], P = 0.014) and multivariable analysis (HR=2.10 [1.20–3.67], P = 0.018). In the matched analysis, recurrence risk was also higher with male donors (HR=1.92 [1.05–3.52], P = 0.034): both in intrahepatic recurrence (HR=1.92 [1.05–3.51], P = 0.034) and extrahepatic recurrence (HR=1.93 [1.05–3.52], P = 0.033). Multivariable analysis confirmed the significance of donor sex (HR=2.08 [1.11–3.91], P = 0.023). Interestingly, the significance was lost when donor age was >40 years. Two external cohorts validated the significance of donor sex. Conclusions: Donor sex appears to be an important graft factor modulating HCC recurrence after living donor liver transplantation.
Dacrystic seizures: A cry for help
Gadoth, Avi , Singh, Jaysingh , Flanagan, Eoin P. , Pittock, Sean J. , Pittock, S J , Britton, Jeffrey W. , Flanagan, E P

Mayo Clinic

Neurology Neuroimmunology & Neuroinflammation | June 17, 2017 | Volume: 4 | Issue: 4 | Pages: No page available

10.1212/nxi.0000000000000372 | PMID 28642892 Get It

Free Tissue Transfers for Head and Neck Reconstruction in Patients with End-Stage Renal Disease on Dialysis: Analysis of Outcomes Using the Taiwan National Health Insurance Research Database
Ciudad, Pedro , Sharaf, Basel , Martinez‐Jorge, Jorys, Moran, Steven, Mardini, Samir , Chen, Hung‐Chi , Bite, Uldis, Cheng, Hsu‐Tang , Manrique, Oscar J. , Chen, Hung‐Chi , Martinez-Jorge, Jorys, Cheng, Hsu-Tang , Sharaf, Basel A

Mayo Clinic

Journal of Reconstructive Microsurgery | June 16, 2017 | Volume: 33 | Issue: 08 | Pages: 587-591

10.1055/s-0037-1603739 | PMID 28622701 Get It

Background Patients diagnosed with end-stage renal disease (ESRD) are increasing at around 5% annually. Some of these patients will require free tissue transfers to reconstruct their body after trauma or cancer resection. Comorbidities can increase the level of complexity during reconstruction. Aim Our goal is to describe the outcomes of ESRD patients under dialysis who underwent free tissue transfer for head and neck reconstruction. Methods Two cohorts were analyzed: ESRD group on dialysis and a non-ESRD control group after free tissue transfer for head and neck reconstruction. Postoperative complications and mortality were recorded. For coexisting comorbidities, we determine the presence of diabetes mellitus (DM) and peripheral vascular disease (PVD). Results In this study, 85 cases with ESRD on dialysis and 841 controls were analyzed. Most patients were aged ≤ 65 years (82.5%) and nearly 92.9% of them were men. Types of head and neck cancer were neoplasm of other and unspecified parts of the mouth followed by neoplasm of tongue, the gingiva, hypopharynx, and floor of mouth. Patients with ESRD tended to have higher rates of DM and PVD (p < 0.001) and were significantly associated with an increased risk of stroke and increased risk of 30-day mortality. However, there was no significant difference regarding flap failure among groups. Conclusion Despite greater preoperative risk factors, patients with renal failure on hemodialysis do not appear to have a higher rate of free flap failure following head and neck reconstruction. However, other complications can be minimized by optimizing patient's medical condition to succeed with this reconstructive effort.
Faculty Opinions recommendation of In situ bone tissue engineering via ultrasound-mediated gene delivery to endogenous progenitor cells in mini-pigs.
Evans, Christopher H.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 16, 2017 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.727623325.793533150 Get It

Ultrasound‐guided hydrodissection decreases gliding resistance of the median nerve within the carpal tunnel
Evers, Stefanie, Thoreson, Andrew R. , Smith, Jay , Zhao, Chunfeng , Geske, Jennifer R. , Amadio, Peter C. , Geske, Jennifer

Mayo Clinic

Muscle & Nerve | June 16, 2017 | Volume: 57 | Issue: 1 | Pages: 25-32

10.1002/mus.25723 | PMID 28622409 Get It

ABSTRACTIntroduction: The aim of this study was to assess alterations in median nerve (MN) biomechanics within the carpal tunnel resulting from ultrasound‐guided hydrodissection in a cadaveric model. Methods: Twelve fresh frozen human cadaver hands were used. MN gliding resistance was measured at baseline and posthydrodissection, by pulling the nerve proximally and then returning it to the origin. Six specimens were treated with hydrodissection, and 6 were used as controls. Results: In the hydrodissection group there was a significant reduction in mean peak gliding resistance of 92.9 ± 34.8 mN between baseline and immediately posthydrodissection (21.4% ± 10.5%; P = 0.001). No significant reduction between baseline and the second cycle occurred in the control group: 9.6 ± 29.8 mN (0.4% ± 5.3%; P = 0.467). Discussion: Hydrodissection can decrease the gliding resistance of the MN within the carpal tunnel, at least in wrists unaffected by carpal tunnel syndrome. A clinical trial of hydrodissection seems justified. Muscle Nerve 57: 25–32, 2018
Mutant Fibulin-3 Causes Proteoglycan Accumulation and Impaired Diffusion Across Bruch's Membrane
Zayas‐Santiago, Astrid , Cross, Samuel D., Stanton, J. Brett, Marmorstein, Alan D. , Marmorstein, Lihua Y., Marmorstein, Alan D

Mayo Clinic

Investigative Opthalmology & Visual Science | June 16, 2017 | Volume: 58 | Issue: 7 | Pages: 3046

10.1167/iovs.17-21720 | PMID 28622396 Get It